CA
NZ
UK
AU
IND
US
Headquartered in Burlington, North Carolina, Labcorp Holdings operates through Diagnostics Laboratories and Biopharma Laboratory Services segments, serving clients in approximately 100 countries. The company's nearly 71,000 employees supported more than 85 percent of new drugs and therapeutic products approved by the FDA in 2025 …
Headquartered in Redwood City, California, Heartflow is a medical technology company focused on transforming coronary artery disease diagnosis through artificial intelligence and computational fluid dynamics. The company's flagship Heartflow Analysis creates patient-specific 3D models of coronary arteries from standard CT scans, allowing clinicians to …
Headquartered in Broomfield, Colorado, AtriCure develops and commercializes solutions for the surgical treatment of atrial fibrillation. The company's flagship AtriCure System includes radiofrequency ablation devices used during cardiac surgery, while the AtriClip device is a surgically implanted left atrial appendage exclusion device that reduces …
Headquartered in Atlanta, Georgia, Aveanna Healthcare provides home health, hospice, private duty nursing, and medical staffing solutions through three divisions across 403 locations in 39 states. The company's strategy centers on optimizing reimbursement through preferred payer relationships, pursuing strategic acquisitions, and targeting the growing …
Headquartered in San Diego, California, Crinetics Pharmaceuticals is a commercial-stage biopharmaceutical company focused on rare endocrine diseases and endocrine-related tumors. The company's lead asset, PALSONIFY, is an oral somatostatin receptor type 2 agonist approved for treating acromegaly, offering a convenient alternative to injectable standard-of-care …
Alvotech (NASDAQ:ALVO) shares are trading up 19.07% today at $5.28, as fresh bullish analyst coverage compounds momentum from last week's biosimilar licensing agreement with Lotus Pharmaceutical. The move builds on a stock that has already been trending higher over the past several sessions.
Kura Oncology, Inc. (NASDAQ:KURA) shares rose in Monday's session as bullish analyst commentary reinforced confidence in the commercial launch of KOMZIFTI (ziftomenib). Citizens reiterated a Market Outperform rating with a $24 price target, citing strong early launch progress in relapsed and refractory NPM1-mutant acute …
Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) shares climbed to near all-time highs in Monday's session as a wave of bullish analyst updates reinforced confidence following the company's strong second-quarter results and raised full-year guidance. RBC Capital lifted its price target to $16 from $10, maintaining …
Shares of this NASDAQ-listed life sciences company are trading down 11.12% today at $33.24, unwinding much of a dramatic multi-month rally after theBusinessdisclosed a sudden leadership transition before the market open. The stock had more than doubled off its 52-week low of $15.93 set …
Nanobiotix S.A. (NASDAQ:NBTX) shares fell sharply in Monday's session on heavy volume, roughly 1.6 times the average, after the company's fourth-quarter and fiscal 2025 earnings report showed earnings per share coming in below Wall Street forecasts despite a revenue beat, extending a post-earnings pullback …
Please wait processing your request...